As the pharmaceutical industry continues to accelerate its digital and intelligent transformation, YENCHEN Machinery remains committed to equipment innovation and process optimization. By collaborating with Siemens Taiwan, YENCHEN integrates advanced automation, digital monitoring, energy management, and carbon management technologies to help customers improve production efficiency, process transparency, and operational resilience.

The report also highlighted the official establishment of the YENCHEN Solid Dosage Technology Center during the company’s 60th anniversary celebration. The center will provide a shared air handling and testing platform for fluid bed processors and coating systems while supporting equipment digitalization and energy-efficiency optimization. Through these initiatives, YENCHEN aims to help pharmaceutical manufacturers meet the growing demands of smart manufacturing and sustainable transformation.

In addition, the implementation of intelligent sensing, remote monitoring, and predictive maintenance technologies enables pharmaceutical manufacturers to monitor equipment performance in real time, reduce unplanned downtime, and comply with FDA 21 CFR Part 11 requirements for electronic records and data traceability. Furthermore, Siemens’ variable frequency drive (VFD) control systems, energy-efficient drive solutions, and operational data analytics help customers identify high-energy-consuming processes, reduce energy consumption, and improve overall production efficiency.

With more than 60 years of experience in pharmaceutical equipment manufacturing, YENCHEN Machinery will continue to embrace smart manufacturing, digital transformation, and ESG principles. Together with its partners and customers, YENCHEN is committed to building a more efficient, low-carbon, and globally competitive future for the pharmaceutical industry.